BIO vs HESM · rev $651.0M vs P/E 13, rev $789.1M
BIO (BIO) versus Hess Midstream Partners LP (HESM) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Hess Midstream Partners LP (HESM) is a oil & gas midstream company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported HESM revenue for 2026-06-30 was $789.1M. Net income was $184.0M. HESM currently screens at market cap $8.02B and trailing P/E 13.4.
BIO currently screens at market cap $0. HESM currently screens at market cap $8.02B and trailing P/E 13.4.
Not investment advice. Open the BIO and HESM stock pages for the full models.
Not investment advice.